Covered recipient · General Payments record
HILDA IVONNE CRUZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$841.64
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.35 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $190.28 | 4 |
| Amgen Inc. | $66.07 | 4 |
| Lilly USA, LLC | $19.23 | 1 |
| Abbott Laboratories | $14.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.77 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125353612 | CMS |
| Amgen Inc. | $16.35 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117231497 | CMS |
| Amgen Inc. | $19.52 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117231499 | CMS |
| Amgen Inc. | $16.26 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117231501 | CMS |
| Amgen Inc. | $13.94 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117231503 | CMS |
| GlaxoSmithKline, LLC. | $19.92 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116270135 | CMS |
| GlaxoSmithKline, LLC. | $20.99 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116398226 | CMS |
| GlaxoSmithKline, LLC. | $24.38 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116396284 | CMS |
| GlaxoSmithKline, LLC. | $124.99 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116664417 | CMS |
| Lilly USA, LLC | $19.23 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135003671 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.